Priapism in neuroleptic therapy
Eikmeier, G.
Der Nervenarzt 58(12): 771-772
1987
ISSN/ISBN: 0028-2804 PMID: 3431614 Document Number: 289727
The case of a 47-year old schizophrenic patient, who developed priapism on the fourth day of treatment with 40 mg Haloperidol and 50 mg Levomepromazin daily, is presented. Clinical aspects and possible mechanisms of pathogenesis are discussed.
Document emailed within 1 workday
Related Documents
Marx, F.J. 1981: Therapy of priapism Der Urologe. Ausg. a 20(6): 353-359Wegmann, R.; Löffelmann, K.; Ribisch, K. 1973: Thrombotic priapism following embolism (streptokinase therapy) Wiener Medizinische Wochenschrift 123(45): 664-667
2009: Aripiprazole and adolescent schizophrenia: a simple neuroleptic. No comparison with standard neuroleptic in adolescents Prescrire international 18(104): 251
Lavie, C.J.; Olmsted, T.R.; Ventura, H.O.; Lepler, B.J. 1986: Neuroleptic malignant syndrome. An underdiagnosed reaction to neuroleptic agents? Postgraduate Medicine 80(3): 171-178
Janssen, P.A.; Niemegeers, C.J.; Schellekens, K.H. 1965: Is it Possible to Predict the Clinical Effects of Neuroleptic Drugs (Major Tranquillizers) from Animal Data?i. "neuroleptic Activity Spectra" for Rats Arzneimittel-Forschung 15: 104-117
Ogura, T. 1986: The safety of long-term neuroleptic therapy Seishin Shinkeigaku Zasshi 88(11): 960-970
Rix, E.; Gless, K.H. 1981: Bradyarrhythmia caused by combined lithium-neuroleptic therapy Deutsche Medizinische Wochenschrift 106(19): 629-630
Fünfgeld, E.W.; Kulhanek, F. 1978: Neuroleptic infusion therapy with high-dosed fluphenazine Arzneimittel-Forschung 28(9): 1489-1491
Ereshefsky, L.; Saklad, S.R.; Jann, M.W.; Davis, C.M.; Richards, A.; Seidel, D.R. 1984: Future of depot neuroleptic therapy: pharmacokinetic and pharmacodynamic approaches Journal of Clinical Psychiatry 45(5 Part 2): 50-59
Niemegeers, C.J. 1974: The predictive value of the anti-apomorphine test in dogs for neuroleptic therapy in man Activitas Nervosa Superior 16(1): 56-58
Patel, A.L.; Shaikh, W.A.; Khobragade, A.K.; Soni, H.G.; Joshi, A.S.; Sahastrabuddhe, G.S. 2008: Electroconvulsive therapy in drug resistant neuroleptic malignant syndrome Journal of the Association of Physicians of India 56: 49-50
Ryzhakov, B.A.; Nuller, I.U. 1992: The use of the bromocriptine test in schizophrenia patients resistant to neuroleptic therapy Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 92(3): 79-80
Favrod, J.ér.ôm.; Pomini, V.; Grasset, F.ço. 2004: Cognitive-behavioral therapy for auditory hallucinations resistant to neuroleptic treatment Revue Medicale de la Suisse Romande 124(4): 213-216
Lindholm, H.; Ljungberg, L. 1973: Comparison of conventional neuroleptic therapy with depot neuroleptics. An attempt at economic evaluation Acta Psychiatrica Scandinavica. Supplementum 246: 52-56
Unglaub, W.; Kandel, M.; Zenner, D.; Wodarz, N.; Klein, H. 2003: Neuroleptic therapy of comorbid narcotic dependent patients in ambulatory methadone maintenance Psychiatrische Praxis 30(Suppl 2): S121-S124
Setoyama, K.; Hirata, T.; Saeki, H.; Morimoto, Y.; Tsuruta, S.; Matsumoto, M.; Sakabe, T. 2009: Anesthetic management for electroconvulsive therapy in the patients with a history of neuroleptic malignant syndrome MASUI. Japanese Journal of Anesthesiology 58(5): 633-636
Johnson, D.A. 1984: Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia Journal of Clinical Psychiatry 45(5 Part 2): 13-21
Pastore, G.; Spadaro, P. 1970: Cyprohepatadine in emaciated psychotics: anti-anorexic action and effect on basic neuroleptic therapy Acta Neurologica 25(3): 372-374
Von Domarus, H. 1973: Extrapyramidal motor disorders in neuroleptic therapy (apparent recurring luxation of mandibular joints) Deutsche Zahnarztliche Zeitschrift 28(11): 1085-1088
Roy, G.B.; Sinha, L. 1972: Priapism Journal of the Indian Medical Association 59(4): 156-157